Tuspark UK Becomes Latest Partner of One Nucleus

Tuspark has become the latest Partner to join forces with One Nucleus, which was established in 1997, It is an award winning not-for-profit Life Sciences & Healthcare membership organisation centred on the Greater London-Cambridge-East of England corridor. Headquartered in Cambridge, at the heart of Europe’s largest Life Sciences & Healthcare cluster, One Nucleus supports those institutions, companies and individuals undertaking activity in or with the above region.

Through providing the local, UK-wide and international connectivity, One Nucleus seeks to enable its members to maximise their performance. This support helping them achieve, or better still exceed, the goals they have set for themselves. Biomedical and Healthcare R&D have always been impactful in driving social and economic progress. In an increasingly outsourced, collaborative and multi-disciplinary sector, bringing the best people together is key to translating great innovation into great products that markedly improve patient outcomes and drive economic development. Attracting and enabling the best people to engage with is at the heart of the One Nucleus team ethos and what it continually strives to deliver.

Kevin Lin, President of Tuspark UK commented ‘Tony and I met at ON Helix last year, after in-depth discussion, we reached a consensus of promoting innovation network and clusters not only in Cambridge but globally. We’re delighted to be a partner of One Nucleus, which is playing a leading role in European life science and healthcare network, and we expect to meet more innovations by connecting global networks of both parties’.

Tony Jones, CEO of One Nucleus expands further ‘We are delighted to welcome Tuspark to the One Nucleus Partner Programme. Their expertise in supporting innovation with facilities and investment are great asset for the life science community. Their engagement in Cambridge, both the substantial investment in Cambridge Science Park and equity investment in local companies are great early examples of their commitment and approach. We are looking forward to developing this partnership to benefit more of our members and the wider Cambridge biotech scene’.